Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Active, not recruiting

Phase Results N/A

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director
Bayer Clinical Trials Contact Contact

Other Locations

Name City State Country Status
Name Unavailable Many Locations Germany Recruiting_status_icon
Name Unavailable Multiple Locations Germany Unknown_status_icon